Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000930413-12-003107
Filing Date
2012-05-15
Accepted
2012-05-15 17:23:56
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 c69657_10q.htm 10-Q 315512
2 c69657_ex31-1.htm EX-31.1 6807
3 c69657_ex31-2.htm EX-31.2 6814
4 c69657_ex32-1.htm EX-32.1 3270
5 c69657_ex32-2.htm EX-32.2 3282
  Complete submission text file 0000930413-12-003107.txt   1903082

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE ibio-20120331.xml EX-101.INS 343877
7 ibio-20120331.xsd EX-101.SCH 12560
8 XBRL CALCULATION FILE ibio-20120331_cal.xml EX-101.CAL 19733
9 XBRL DEFINITION FILE ibio-20120331_def.xml EX-101.DEF 61847
10 XBRL LABEL FILE ibio-20120331_lab.xml EX-101.LAB 86925
11 XBRL PRESENTATION FILE ibio-20120331_pre.xml EX-101.PRE 64136
Mailing Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711
Business Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35023 | Film No.: 12846227
SIC: 2834 Pharmaceutical Preparations